172 related articles for article (PubMed ID: 16489030)
1. The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma.
Hickson JA; Huo D; Vander Griend DJ; Lin A; Rinker-Schaeffer CW; Yamada SD
Cancer Res; 2006 Feb; 66(4):2264-70. PubMed ID: 16489030
[TBL] [Abstract][Full Text] [Related]
2. Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7.
Vander Griend DJ; Kocherginsky M; Hickson JA; Stadler WM; Lin A; Rinker-Schaeffer CW
Cancer Res; 2005 Dec; 65(23):10984-91. PubMed ID: 16322247
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma.
Yamada SD; Hickson JA; Hrobowski Y; Vander Griend DJ; Benson D; Montag A; Karrison T; Huo D; Rutgers J; Adams S; Rinker-Schaeffer CW
Cancer Res; 2002 Nov; 62(22):6717-23. PubMed ID: 12438272
[TBL] [Abstract][Full Text] [Related]
4. Stress-activated kinase pathway alteration is a frequent event in bladder cancer.
Otto KB; Acharya SS; Robinson VL
Urol Oncol; 2012; 30(4):415-20. PubMed ID: 22154358
[TBL] [Abstract][Full Text] [Related]
5. c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation.
Lotan T; Hickson J; Souris J; Huo D; Taylor J; Li T; Otto K; Yamada SD; Macleod K; Rinker-Schaeffer CW
Cancer Res; 2008 Apr; 68(7):2166-75. PubMed ID: 18381422
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of MKK4, MKK6 and MKK7 during prostate cancer progression: an important role for SAPK signalling in prostatic neoplasia.
Lotan TL; Lyon M; Huo D; Taxy JB; Brendler C; Foster BA; Stadler W; Rinker-Schaeffer CW
J Pathol; 2007 Aug; 212(4):386-94. PubMed ID: 17577251
[TBL] [Abstract][Full Text] [Related]
7. New paradigms for the function of JNKK1/MKK4 in controlling growth of disseminated cancer cells.
Taylor JL; Szmulewitz RZ; Lotan T; Hickson J; Griend DV; Yamada SD; Macleod K; Rinker-Schaeffer CW
Cancer Lett; 2008 Dec; 272(1):12-22. PubMed ID: 18572308
[TBL] [Abstract][Full Text] [Related]
8. Distinct signaling properties of mitogen-activated protein kinase kinases 4 (MKK4) and 7 (MKK7) in embryonic stem cell (ESC) differentiation.
Wang J; Chen L; Ko CI; Zhang L; Puga A; Xia Y
J Biol Chem; 2012 Jan; 287(4):2787-97. PubMed ID: 22130668
[TBL] [Abstract][Full Text] [Related]
9. Mitogen Kinase Kinase (MKK7) Controls Cytokine Production In Vitro and In Vivo in Mice.
Caliz AD; Yoo HJ; Vertii A; Dolan AC; Tournier C; Davis RJ; Keaney JF; Kant S
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502275
[TBL] [Abstract][Full Text] [Related]
10. Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17.
Yoshida BA; Dubauskas Z; Chekmareva MA; Christiano TR; Stadler WM; Rinker-Schaeffer CW
Cancer Res; 1999 Nov; 59(21):5483-7. PubMed ID: 10554023
[TBL] [Abstract][Full Text] [Related]
11. Mitogen-activated protein kinase kinase 4/c-Jun NH2-terminal kinase kinase 1 protein expression is subject to translational regulation in prostate cancer cell lines.
Robinson VL; Shalhav O; Otto K; Kawai T; Gorospe M; Rinker-Schaeffer CW
Mol Cancer Res; 2008 Mar; 6(3):501-8. PubMed ID: 18337456
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the metastasis suppressor gene MKK4 in ovarian cancer.
Spillman MA; Lacy J; Murphy SK; Whitaker RS; Grace L; Teaberry V; Marks JR; Berchuck A
Gynecol Oncol; 2007 May; 105(2):312-20. PubMed ID: 17276500
[TBL] [Abstract][Full Text] [Related]
13. The bottleneck of JNK signaling: molecular and functional characteristics of MKK4 and MKK7.
Haeusgen W; Herdegen T; Waetzig V
Eur J Cell Biol; 2011; 90(6-7):536-44. PubMed ID: 21333379
[TBL] [Abstract][Full Text] [Related]
14. MEKK4 stimulation of p38 and JNK activity is negatively regulated by GSK3beta.
Abell AN; Granger DA; Johnson GL
J Biol Chem; 2007 Oct; 282(42):30476-84. PubMed ID: 17726008
[TBL] [Abstract][Full Text] [Related]
15. Cell-type-specific activation of p38 protein kinase cascades by the novel tumor promoter palytoxin.
Li S; Wattenberg EV
Toxicol Appl Pharmacol; 1999 Oct; 160(2):109-19. PubMed ID: 10527909
[TBL] [Abstract][Full Text] [Related]
16. Mkk4 and Mkk7 are important for retinal development and axonal injury-induced retinal ganglion cell death.
Syc-Mazurek SB; Rausch RL; Fernandes KA; Wilson MP; Libby RT
Cell Death Dis; 2018 Oct; 9(11):1095. PubMed ID: 30367030
[TBL] [Abstract][Full Text] [Related]
17. Selective activation of tumor-suppressive MAPKP signaling pathway by triptonide effectively inhibits pancreatic cancer cell tumorigenicity and tumor growth.
Zhang B; Meng M; Xiang S; Cao Z; Xu X; Zhao Z; Zhang T; Chen B; Yang P; Li Y; Zhou Q
Biochem Pharmacol; 2019 Aug; 166():70-81. PubMed ID: 31075266
[TBL] [Abstract][Full Text] [Related]
18. Role of mitogen-activated protein kinase kinase 4 in cancer.
Whitmarsh AJ; Davis RJ
Oncogene; 2007 May; 26(22):3172-84. PubMed ID: 17496914
[TBL] [Abstract][Full Text] [Related]
19. Diverse physiological functions of MKK4 and MKK7 during early embryogenesis.
Asaoka Y; Nishina H
J Biochem; 2010 Oct; 148(4):393-401. PubMed ID: 20801953
[TBL] [Abstract][Full Text] [Related]
20. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
Chuang SM; Wang IC; Yang JL
Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
